Staburo Academy online course “Advanced statistical methods”
Our course “Advanced statistical methods” will be a 2-day course from 08 to 09 April 2021!
News
BioNTech Recognizes Staburo as Partner for Support in Developing Covid-19 Vaccine
BioNTech recognizes employees and partners for their support in developing historic vaccine
We thank BioNTech for recognizing our biostatistics support in the development of a vaccine against COVID-19! We were very happy to add our expertise to this meaningful project and thank the whole team!
Staburo Academy Online Course Introduction to R
Our course “Introduction to R course” will be a 2-day course from 28 to 29 January 2021! The course will be held in English and the detailed agenda will be sent out a few days before the start of the course. You find more details here!
G-BA Approves Staburo Supported Study on Cancer Treatment through Stem Cell Transplantation
A new study in collaboration with Universitätsklinikum Hamburg-Eppendorf (UKE) and CTC North GmbH & Co. KG has been approved by the German Gemeinsamer Bundesausschuss (G-BA) on December 4. The G-BA has commissioned the UKE to research the benefits of allogeneic stem cell transplantation to treat multiple myeloma in relapsed/progressive patients.
Introduction to Statistics Online Course
Our first course “Introduction to Statistics course” will be a 2-day course 02-03 November 2020!
Staburo GmbH Launches “Staburo Academy”
Apply now on www.staburo.de/academy/ !
Staburo Supports Research on the Impact of Coronavirus Disease on Methodological Aspects of ongoing Clinical Trials
On behalf of Staburo, Josef Höfler and our former colleague Nicole Krämer submitted comments on the EMA’s draft guidance on “Points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials”. The guidance, set...
Staburo Supported Evaluation of Medical Device which recently got FDA Emergency Use Authorization for COVID-19
Staburo Managing Director Dr. Hannes Buchner and our team was involved in statistical consulting and performing data analysis in a trial for a medical device which is now being used in COVID-19 patients. The device binds SARS-CoV-2 and removes it from the blood. It...
Staburo at the G-BA in Berlin
Josef Höfler from Staburo participated as statistical expert in an advisory meeting at the institution of “Gemeinsamer Bundesausschuss” in Berlin, in the context of health technology assessment. The Federal Joint Committee (G-BA) is the highest decision-making body of...
Staburo Wiesn-Workshop 2019
It is a very nice custom to have our Staburo statistics training session on the first Monday of the two-week Oktoberfest period. This year, the Staburo team had the chance to learn about our new R shiny App in the first presentation “OTTO – Demonstration and...
Interview with Staburo Managing Director Dr. Hannes Buchner
Interview with Dr. Hannes Buchner, Head of Biostatistics at Staburo GmbH
This interview was conducted by Felicitas Bahr.
Scientific Advice @BfArM
Staburo’s Managing Director Josef Höfler prepared and took part in a Scientific Advice meeting at the agency BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) in Bonn.